ADAM VOGEL to Biomarkers
This is a "connection" page, showing publications ADAM VOGEL has written about Biomarkers.
Connection Strength
0.348
-
Characterization of central manifestations in patients with Niemann-Pick disease type C. Genet Med. 2024 03; 26(3):101053.
Score: 0.107
-
Using Smartphone Sensors for Ataxia Trials: Consensus Guidance by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers. Cerebellum. 2024 Jun; 23(3):912-923.
Score: 0.107
-
Features of speech and swallowing dysfunction in pre-ataxic spinocerebellar ataxia type 2. Neurology. 2020 07 14; 95(2):e194-e205.
Score: 0.084
-
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis. EBioMedicine. 2025 Aug; 118:105840.
Score: 0.030
-
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial. Ann Oncol. 2020 06; 31(6):789-797.
Score: 0.021